Alcon is a global leader in eye care, specializing in the development, manufacturing and distribution of surgical equipment and vision care products. The company operates through two primary business segments—Surgical and Vision Care—to serve the full spectrum of ophthalmic needs. Its Surgical business provides advanced technologies for cataract, vitreoretinal, refractive and glaucoma procedures, while its Vision Care division offers daily disposable and reusable contact lenses along with lens care solutions.
Within the Surgical segment, Alcon’s portfolio includes phacoemulsification systems, intraocular lenses and laser systems designed to enhance surgical precision and patient outcomes. The Vision Care segment features brands such as DAILIES®, PRECISION1® and TOTAL30® contact lenses, plus associated cleaning and disinfecting solutions. Alcon’s products reach ophthalmologists, optometrists and patients in over 140 countries, supported by regional manufacturing facilities, clinical training centers and a global sales force.
Originally founded in Fort Worth, Texas, in 1945 by Robert Alexander and William Conner, Alcon grew from a single storefront pharmacy into a standalone eye care company. Headquartered in Geneva, Switzerland, since its 2019 spin-off from Novartis, Alcon maintains research and development hubs in Europe, North America and Asia. Under the leadership of Chief Executive Officer David Endicott and Chief Financial Officer John P. Wiley, the company continues to invest in innovation aimed at improving vision health worldwide.
AI Generated. May Contain Errors.
